Donanemab: FDA experts recommend approval of Alzheimer’s drug
Owen Dyer
Topics & Concepts
Drug approvalMedicineDrugDrug trialApproved drugData sciencePharmacologyComputer scienceClinical trialPathologyDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsHealth Systems, Economic Evaluations, Quality of Life